If you’re a life science marketer, chances are you’ve been hearing about the difference artificial intelligence (AI) and real-world data (RWD) can make in HCP targeting and engagement. But for all the hype, many marketers have struggled to find effective, actionable ways to turn these tools into executable programs.
The primary challenge lies in the inherent time lag associated with pulling actionable insight from real-world data assets. Claims data – a common data asset used to create marketing strategy – is retrospective by nature. Even when data is received in real-time, by the time it’s modeled to predict HCP activity, the patients it's based on are gone, limiting the model’s applicability to present-day use. Some of the challenges marketers face when using this data include:
Artificial intelligence and real-world data have the potential to make a real difference in HCP engagement campaigns – by using them in a novel way.
To implement an effective AI- and RWD-driven HCP targeting strategy, you need to align your ask of the data to the answers it is best suited to provide. That means shifting your approach to focus on the real-world data assets that tell us about a patient’s longitudinal journey through current care milestones, then using an AI model to predict their future care windows and treatment needs.
Instead of asking “how likely is this HCP to see brand-eligible patients?”, ask “when in this patient’s journey are they likely to be qualified for treatment, and when/where are they likely to be meeting with their provider?” From there, you can focus on engaging their HCP with the content that is most relevant to that patient – at that critical juncture in their journey.
By applying AI and using RWD in its appropriate historical context, you can avoid the challenges of data ingestion lags, while still personalizing your communications to reflect current patient and HCP situations. At OptimizeRx, this is our approach to implementing dynamic HCP targeting.
Our approach to dynamic HCP targeting predicts the window in time when a potentially treatment-qualified patient will be meeting with their provider, and engages that HCP with treatment information targeted to the verified needs of the patients they are currently seeing.
As a result, this framework allows life science companies to deliver contextual, actionable information with immediate value to both the physician and the patient. Here’s what that means for providers, patients and your brand:
Ultimately, both HCPs and life sciences companies seek to improve patient outcomes, and dynamic HCP targeting is a better way to use AI and RWD to reach that goal.
Interested in learning more about the difference a dynamic HCP targeting makes?
Explore OptimizeRx Dynamic Audience Activation Platform (DAAP).
OptimizeRx is at the forefront of revolutionizing the way healthcare professionals interact with patients and manage medication adherence. With its innovative solutions, OptimizeRx makes it easier for healthcare providers to support their patients in navigating the complexities of medication management, while offering patients the tools they need to stay healthy and engaged in their care.
For healthcare providers looking to improve medication adherence, enhance patient communication, and reduce the financial barriers to treatment, OptimizeRx offers a seamless and effective digital health solution. Together, we can move closer to a world where adherence is the norm, not the exception—and better health outcomes follow.